{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-211305","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2025-09-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.172644+00:00","generated_at":"2026-05-17T05:59:44.668263+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BioAtla granted Nasdaq continued listing with conditions through Feb 2026","bullets":["Nasdaq Panel approved continued listing pending transfer to Capital Market by Sept 26, 2025 (filed Sept 18).","Must demonstrate compliance with Minimum Stockholders' Equity Requirement by Dec 31, 2025.","Must demonstrate compliance with Minimum Bid Price Requirement by Feb 2, 2026.","Company believes it can meet both deadlines but provides no assurance.","Previously disclosed delisting risk from failure to meet bid price and equity requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-211305","json":"https://secwatch.observer/filing/0001193125-25-211305.json","markdown":"https://secwatch.observer/filing/0001193125-25-211305.md","text":"https://secwatch.observer/filing/0001193125-25-211305.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000119312525211305/0001193125-25-211305-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000119312525211305/bcab-20250916.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:59:44.668263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}